• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对主要生物战剂的有效医学应对措施的研发:抗体的重要性

Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies.

作者信息

Avril Arnaud, Guillier Sophie, Rasetti-Escargueil Christine

机构信息

Unité Interaction Hôte-Pathogène, Département Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées, 91220 Brétigny-sur-Orge, France.

Unité Bactériologie, Département Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées, 91220 Brétigny-sur-Orge, France.

出版信息

Microorganisms. 2024 Dec 18;12(12):2622. doi: 10.3390/microorganisms12122622.

DOI:10.3390/microorganisms12122622
PMID:39770824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11677989/
Abstract

The COVID-19 and mpox crisis has reminded the world of the potentially catastrophic consequences of biological agents. Aside from the natural risk, biological agents can also be weaponized or used for bioterrorism. Dissemination in a population or among livestock could be used to destabilize a nation by creating a climate of terror, by negatively impacting the economy and undermining institutions. The Centers for Disease Control and Prevention (CDC) classify biological agents into three categories (A or Tier 1, B and C) according to the risk they pose to the public and national security. Category A or Tier 1 consists of the six pathogens with the highest risk to the population (, , , botulinum neurotoxins, smallpox and viral hemorrhagic fevers). Several medical countermeasures, such as vaccines, antibodies and chemical drugs, have been developed to prevent or cure the diseases induced by these pathogens. This review presents an overview of the primary medical countermeasures, and in particular, of the antibodies available against the six pathogens on the CDC's Tier 1 agents list, as well as against ricin.

摘要

新冠疫情和猴痘危机让全世界意识到生物制剂可能带来的灾难性后果。除了自然风险外,生物制剂还可能被武器化或用于生物恐怖主义。在人群或牲畜中传播生物制剂,可能会制造恐怖气氛、对经济产生负面影响并破坏机构稳定,从而使一个国家陷入动荡。美国疾病控制与预防中心(CDC)根据生物制剂对公众和国家安全构成的风险,将其分为三类(A类或1级、B类和C类)。A类或1级包括对人群风险最高的六种病原体(炭疽杆菌、肉毒杆菌神经毒素、鼠疫杆菌、天花病毒和病毒性出血热病毒)。为预防或治疗这些病原体引发的疾病,人们已研发出多种医学应对措施,如疫苗、抗体和化学药物。本综述概述了主要的医学应对措施,特别是针对美国疾病控制与预防中心1级制剂清单上六种病原体以及蓖麻毒素的可用抗体。

相似文献

1
Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies.针对主要生物战剂的有效医学应对措施的研发:抗体的重要性
Microorganisms. 2024 Dec 18;12(12):2622. doi: 10.3390/microorganisms12122622.
2
Therapeutic Antibodies for Biodefense.生物防御治疗性抗体
Adv Exp Med Biol. 2017;1053:173-205. doi: 10.1007/978-3-319-72077-7_9.
3
Antibodies for biodefense.用于生物防御的抗体。
MAbs. 2011 Nov-Dec;3(6):517-27. doi: 10.4161/mabs.3.6.17621. Epub 2011 Nov 1.
4
A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, and .一种可抵御两种一级生物恐怖病原体(炭疽和鼠疫)的二价疫苗
Front Immunol. 2017 Jun 26;8:687. doi: 10.3389/fimmu.2017.00687. eCollection 2017.
5
A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.基于噬菌体 T4 纳米颗粒的炭疽和鼠疫双重疫苗
mBio. 2018 Oct 16;9(5):e01926-18. doi: 10.1128/mBio.01926-18.
6
Being prepared: bioterrorism and mass prophylaxis: part I.做好准备:生物恐怖主义与大规模预防:第一部分
Adv Emerg Nurs J. 2014 Jul-Sep;36(3):226-38; quiz 239-40. doi: 10.1097/TME.0000000000000029.
7
Being prepared: bioterrorism and mass prophylaxis: part II.做好准备:生物恐怖主义与大规模预防:第二部分。
Adv Emerg Nurs J. 2014 Oct-Dec;36(4):307-17; quiz 318-9. doi: 10.1097/TME.0000000000000034.
8
Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.单载体平台疫苗可预防炭疽、鼠疫和兔热病 1 级选择剂的致死性呼吸道挑战。
Sci Rep. 2018 May 3;8(1):7009. doi: 10.1038/s41598-018-24581-y.
9
Reevaluating limits of detection of 12 lateral flow immunoassays for the detection of Yersinia pestis, Francisella tularensis, and Bacillus anthracis spores using viable risk group-3 strains.重新评估使用存活的 3 级风险群菌株检测鼠疫耶尔森菌、土拉弗朗西斯菌和炭疽芽孢杆菌孢子的 12 种侧向流动免疫分析检测限。
J Appl Microbiol. 2021 Apr;130(4):1173-1180. doi: 10.1111/jam.14863. Epub 2020 Oct 2.
10
[Bioterrorism and pathogenic microorganisms].[生物恐怖主义与致病微生物]
Hist Cienc Saude Manguinhos. 2013 Oct;20(4):1735-49. doi: 10.1590/S0104-597020130005000016.

引用本文的文献

1
A Lyophilizable Nanoparticle Vaccine Specific for a Novel Linear Neutralizing Epitope in the α2-α3 Helices of Domain 3 of Lethal Factor from .一种针对来自致死因子第3结构域α2-α3螺旋中新型线性中和表位的冻干纳米颗粒疫苗。
Toxins (Basel). 2025 Aug 20;17(8):422. doi: 10.3390/toxins17080422.

本文引用的文献

1
Antibodies to watch in 2024.2024 年值得关注的抗体药物
MAbs. 2024 Jan-Dec;16(1):2297450. doi: 10.1080/19420862.2023.2297450. Epub 2024 Jan 5.
2
Efficacy of different AV7909 dose regimens in a nonclinical model of pulmonary anthrax.不同 AV7909 剂量方案在非临床肺炭疽模型中的疗效。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2290345. doi: 10.1080/21645515.2023.2290345. Epub 2023 Dec 19.
3
A human bispecific antibody neutralizes botulinum neurotoxin serotype A.一种人源双特异性抗体中和 A 型肉毒神经毒素。
Sci Rep. 2023 Nov 27;13(1):20806. doi: 10.1038/s41598-023-48008-5.
4
Pathogenicity and virulence of . 的致病性和毒力。
Virulence. 2023 Dec;14(1):2274638. doi: 10.1080/21505594.2023.2274638. Epub 2023 Nov 8.
5
Tecovirimat Resistance in Mpox Patients, United States, 2022-2023.2022-2023 年美国猴痘患者中特考韦瑞玛的耐药情况。
Emerg Infect Dis. 2023 Dec;29(12):2426-2432. doi: 10.3201/eid2912.231146. Epub 2023 Oct 19.
6
Tetanus toxin and botulinum neurotoxin-derived fusion molecules are effective bivalent vaccines.破伤风毒素和肉毒神经毒素衍生的融合分子是有效的双价疫苗。
Appl Microbiol Biotechnol. 2023 Dec;107(23):7197-7211. doi: 10.1007/s00253-023-12796-7. Epub 2023 Sep 23.
7
Standardization of the Japanese National Standard, Equine Botulinum Antitoxin Type A, and Factors Affecting Standardization.日本国家标准马用 A 型肉毒抗毒素的标准化及其影响因素。
Jpn J Infect Dis. 2024 Jan 24;77(1):16-20. doi: 10.7883/yoken.JJID.2023.063. Epub 2023 Aug 31.
8
Botulinum neurotoxins: Future innovations.肉毒神经毒素:未来的创新。
Medicine (Baltimore). 2023 Jul 1;102(S1):e32378. doi: 10.1097/MD.0000000000032378.
9
Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact.肉毒毒素(A型肉毒毒素)治疗颈肌张力障碍:发展、见解和影响。
Medicine (Baltimore). 2023 Jul 1;102(S1):e32403. doi: 10.1097/MD.0000000000032403.
10
Anti-ricin toxin human neutralizing antibodies and DMAbs protection against ricin toxin poisoning.抗蓖麻毒素人源中和抗体和双抗体对蓖麻毒素中毒的保护作用。
Toxicol Lett. 2023 Jul 1;383:152-161. doi: 10.1016/j.toxlet.2023.06.008. Epub 2023 Jun 28.